FiercePharma9 天
Novo Nordisk slashes prices of additional insulin products but not until 2026
Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...
Taiwan News11 天
Rapid Acting Insulin Market is projected to groww with magnificent CAGR 2033 Exclusive Report
The global rapid acting insulin market was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027. The growth of the global rapid acting ...
As insulin shortages persist, what diabetes patients can do
Earlier this year, the drugmaker reported shortages of NovoLog insulin. Drug companies recommend patients check with their ...
Business Insider India1 年
There's something odd about the way insulin prices change
A 10 ml vial of Sanofi's long-acting insulin Lantus first hit the US market ... an increase of 1,124% over 20 years. Novo Nordisks's Novolog first hit the market in August 2001 at $39.75, and ...